We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
25 Jun 2026 - 27 Jun 2026
08 Jul 2026 - 10 Jul 2026

Nanogen to Acquire SYN X Pharma

By HospiMedica staff writers
Posted on 24 Feb 2004
In a move that will provide the company with a pipeline of complementary diagnostic products, Nanogen, Inc. More...
(San Diego, CA, USA) has agreed to acquire SYN X Pharma, Inc. (Toronto, Canada) in an all-stock transaction.

SYN X is preparing to commercialize a point-of-care diagnostic product for congestive heart failure (CHF) as a result of a worldwide license to the marker NT-pro-BNP (N-terminal pro-hormone brain natriuretic peptide) from Roche Diagnostics. SYN X's test will offer stability at room temperature and quicker results. The company currently markets point-of-care diagnostic tests for myocardial infarction, infectious diseases, and drugs of abuse; and is developing a line of tests under the brand name Nexus Dx for insulin resistance and traumatic brain injury.

"The acquisition of SYN X supports Nanogen's long-term strategy to commercialize advanced diagnostics that enhance the level of medical care for the detection, diagnosis, monitoring, and treatment of disease,” said Howard Birndorf, chairman and CEO of Nanogen. The company intends to operate SYN X as a business unit and to retain the SYN X brand name and the Toronto research facility.




Related Links:
Nanogen
SYN X

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Wound Irrigation Solution
Prontosan®
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.